glp 1 oral supplements Eli Lilly's GLP-1 Therapy Foundayo (orforglipron) Is Now Available for Weight Loss NutraBetic GLP-1 Companion, Supports GLP-1,

doi: 10.1080/14656566.2019.1571040 122 GenoveseSMannucciECerielloA

The law (Medicare Modernization Act of 2003) explicitly excludes drugs when used for weight loss, weight gain, or anorexia. (ASPE) Some proposed changes (including reinterpreting the exclusion for obesity) were considered , but in April 2025 those were not finalized

Patients with type 2 diabetes or obesity should consult a healthcare provider to determine if this treatment is appropriate

7 In this regard, compounding pharmacies may prepare a version of the drug when there is a reported shortage, as is the case with Ozempic and Wegovy

Wilson JM, Nikooienejad A, Robins DA, Roell WC, Riesmeyer JS, Haupt A, et al

Potential Risks Sub-therapeutic dosing may delay A1C control for diabetic patients